Neurology·Springfield, IL

Southern Illinois University

Signal lift35%75%+40 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
227–267
p10 – p90
Sample N
807
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.5%
4 of 66 applicants
01Cohort funnelthis cycle
N = 807
Applied
807
100.0%
Invited
66
8.2%
Class size
4
0.5%
J-1 visaF-1 visaCategorical
Your fitSouthern Illinois University Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at Southern Illinois University Program

Create free account
Contact
JK
Program Director
Jeremy Kulacz, MD
Email director
MC
Program Coordinator
Mindy J Conlee, BA
Email coordinator
Training sites3 hospitals · Springfield
  • 1
    Springfield Memorial Hospital
    Springfield, IL
    Primary
  • 2
    Southern Illinois University School of Medicine
    Springfield, IL
    Sponsor
  • 3
    St John's Hospital
    Springfield, IL
    Participant
Score rangesinvited cohort
USMLE Step 2 CK227267
180205230255280

Level 2 CE data not available

Interview rates
US MD
18%
US DO
9%
US IMG
4%
Non-US IMG
7%
Applicant origin
In-state
54%
Out-of-state
6%
Interview prepNeurology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesNeurology · 25-26
Save this program

Add Southern Illinois University to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Neurology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.